These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2617675)

  • 1. Effect of treatment of chronic theileriosis with buparvaquone on milk yields.
    Michael SA; el Refaii AH; McHardy N; Rae DG
    Trop Anim Health Prod; 1989 Nov; 21(4):218-22. PubMed ID: 2617675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic efficacy of buparvaquone in experimentally induced Theileria annulata infection in calves.
    Bansal GC; Sharma NN
    Vet Parasitol; 1989 Oct; 33(3-4):219-24. PubMed ID: 2815531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of experimentally induced Theileria annulata infection in cross-bred calves with buparvaquone.
    Dhar S; Malhotra DV; Bhushan C; Gautam OP
    Vet Parasitol; 1988 Mar; 27(3-4):267-75. PubMed ID: 3369076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of bovine tropical theileriosis with buparvaquone.
    Sharma NN; Mishra AK
    Trop Anim Health Prod; 1990 Feb; 22(1):63-5. PubMed ID: 2321263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic value of parvaquone and buparvaquone against Theileria annulata infection of cattle.
    Hashemi-Fesharki R
    Res Vet Sci; 1991 Mar; 50(2):204-7. PubMed ID: 2034901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone.
    McHardy N; Wekesa LS; Hudson AT; Randall AW
    Res Vet Sci; 1985 Jul; 39(1):29-33. PubMed ID: 3929346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evidence for the resistance of Theileria annulata to buparvaquone.
    Mhadhbi M; Naouach A; Boumiza A; Chaabani MF; BenAbderazzak S; Darghouth MA
    Vet Parasitol; 2010 May; 169(3-4):241-7. PubMed ID: 20185242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic efficacy of buparvaquone (buparvon) in cattle with theileriosis].
    Saruhan B; Paşa S
    Turkiye Parazitol Derg; 2008; 32(4):317-21. PubMed ID: 19156603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of buparvaquone in milk and tissue of dairy cows.
    McDougall S; Hillerton JE; Pegram D
    N Z Vet J; 2016 Nov; 64(6):318-23. PubMed ID: 27373797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of theileriosis in crossbred cattle in the Punjab.
    Singh J; Gill JS; Kwatra MS; Sharma KK
    Trop Anim Health Prod; 1993 May; 25(2):75-8. PubMed ID: 8236482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of the effect of Theileria orientalis Ikeda type infection on three New Zealand dairy farms naturally infected at pasture.
    Lawrence KE; Gedye K; Pomroy WE
    Vet Parasitol; 2019 Dec; 276():108977. PubMed ID: 31775104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic trials with four drugs in crossbred calves experimentally infected with Theileria annulata.
    Singh DK; Thakur M; Raghav PR; Varshney BC
    Res Vet Sci; 1993 Jan; 54(1):68-71. PubMed ID: 8434151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of buparvaquone treatment on the levels of some antioxidant vitamins, lipid peroxidation and glutathione peroxidase in cattle with theileriosis.
    Naziroğlu M; Saki CE; Sevgili M
    Zentralbl Veterinarmed B; 1999 May; 46(4):233-9. PubMed ID: 10379233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence Polymorphism of Cytochrome b Gene in Theileria annulata Tunisian Isolates and Its Association with Buparvaquone Treatment Failure.
    Mhadhbi M; Chaouch M; Ajroud K; Darghouth MA; BenAbderrazak S
    PLoS One; 2015; 10(6):e0129678. PubMed ID: 26061414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of Theileria buffeli infections from cattle by concurrent treatment with buparvaquone and primaquine phosphate.
    Stewart NP; de Vos AJ; McHardy N; Standfast NF
    Trop Anim Health Prod; 1990 May; 22(2):116-22. PubMed ID: 2115213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evaluation of the use of buparvaquone in the infection and treatment method of immunizing cattle against Theileria parva derived from African buffalo (Syncerus caffer).
    Ngumi PN; Young AS; Lampard D; Mining SK; Ndungu SG; Lesan AC; Williamson SM; Linyonyi A; Kariuki DP
    Vet Parasitol; 1992 Jun; 43(1-2):15-24. PubMed ID: 1496799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific activity in vitro on the Theileria infection process of serum from calves treated prophylactically with buparvaquone.
    Wilkie GM; Kirvar E; Thomas EM; Sparagano O; Brown CG
    Vet Parasitol; 1998 Dec; 80(2):127-36. PubMed ID: 9870365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and application of TaqMan real-time PCR method for detection of Theileria annulata resistant to buparvaquone.
    Su S; Zhao S; Liu J; Zhang C; Zhu H; Guan G; Yin H; Luo J
    Vet Parasitol; 2024 Jun; 328():110183. PubMed ID: 38608378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of buparvaquone against Theileria cervi in white-tailed deer.
    Mitema ES; Kocan AA; Mukolwe SW; Sangiah S; Sherban D
    Vet Parasitol; 1991 Jan; 38(1):49-53. PubMed ID: 1902608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutations in the Theileria annulata cytochrome b gene is associated with buparvaquone treatment failure.
    Sharifiyazdi H; Namazi F; Oryan A; Shahriari R; Razavi M
    Vet Parasitol; 2012 Jul; 187(3-4):431-5. PubMed ID: 22305656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.